Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid with chemotherapy in aged lung cancer
NCT01737216Phase 2Unknown
- Sponsor
- Hebei Cancer Hospital
- Start
- Nov 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in lung cancer, sponsored by Hebei Cancer Hospital. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT01737216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737216.